The Scientist

» clinical trials and immunology

Most Recent

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: Medical Marijuana: Where’s the Data?

Medical Marijuana: Where’s the Data?

By | June 30, 2014

As more states legalize therapeutic cannabis, some caution against overprescribing the drug, the benefits of which have not been rigorously tested in clinical trials.

2 Comments

image: Protein Clumps Spread Inflammation

Protein Clumps Spread Inflammation

By | June 22, 2014

ASC specks—protein aggregations that drive inflammation—are released from dying immune cells, expanding the reach of a defense response.

1 Comment

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Ancient Apoptosis

Ancient Apoptosis

By | June 9, 2014

Humans and coral share a cell-death pathway that has been conserved between them for more than half a billion years.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: Immunology and Neurology Pioneer Dies

Immunology and Neurology Pioneer Dies

By | May 24, 2014

Gerald Edelman, who broke new ground in two distinct fields of life science, has passed away at age 84.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS